EHAVE, Inc. (EHVVF)
OTC Markets OTCID
Price as at 30 Sept 2026, 17:44 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
EHAVE, Inc. trades at $0.00. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About EHAVE, Inc.
EHAVE, Inc., a healthcare company, develops medical psychedelics and mental health data platform that integrates with proprietary and third-party assessment and therapeutic digital applications in Canada. The company offers MegaTeam and Ninja Reflex, a clinically validated digital assessment and rehabilitation software for the patient; and adapts third-party clinically validated digital assessment and rehabilitation software for patient engagement and data modeling. It also provides Ehave Dashboard, a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using blockchain technology. In addition, the company offers a platform for medical practitioners to administer healthcare services to patients at home. It serves clinicians, patients, researchers, pharmaceutical companies, and payors. EHAVE, Inc. was incorporated in 2011 and is headquartered in Miami, Florida.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Common questions
Where does SteadyShares get its EHVVF data?
Fundamentals for EHVVF come from company filings and exchange data, as listed on OTC Markets OTCID; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 17:44 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for EHVVF, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.
